Azenta (AZTA) vs Sanara MedTech (SMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Azenta (AZTA) has outperformed Sanara MedTech (SMTI) over the past year, gaining 11.7% versus a gain of 8.4%. Over five years, SMTI leads with a +6.3% price change compared with -65.2% for AZTA. Azenta is the larger company by market cap ($1.67 billion vs $321.9 million), about 5.2 times the size.
On valuation, Sanara MedTech trades at a lower forward P/E (64.9x vs 68.9x for Azenta).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZTA | SMTI |
|---|---|---|
| Share price | $38.09 | $35.04 |
| Market cap | $1.67B | $321.95M |
| 1-day change | +5.81% | -0.03% |
| YTD return | +8.24% | +50.11% |
| 1-year return | +11.70% | +8.41% |
| 5-year return | -65.20% | +6.28% |
| Forward P/E | 68.94 | 64.89 |
| EPS (TTM) | $-2.47 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $593.82M | — |
| Revenue growth (YoY) | +3.55% | — |
| Net income (latest FY) | $-55.76M | — |
| Gross margin | 45.52% | — |
| Operating margin | -4.52% | — |
| Net margin | -9.39% | — |
| 52-week high | $46.41 | $35.34 |
| 52-week low | $15.93 | $16.05 |
| Distance from 52-week high | -17.93% | -0.85% |
| Analyst consensus | buy | none |
| Avg. price target upside | -2.86% | -0.11% |
| Average volume | 875.72K | 280.40K |
| Shares outstanding | 43.81M | 9.19M |
| Employees | 2,900 | 108 |
| Sector | Technology | Health Care |
| Industry | Industrial Machinery/Components | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Azenta is about 5.2 times larger than Sanara MedTech by market value ($1.67B vs $321.95M).
- The two companies sit in different sectors: Azenta in Technology and Sanara MedTech in Health Care.
About Azenta
AZTA stock →Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
Technology · Industrial Machinery/Components · 2,900 employees
About Sanara MedTech
SMTI stock →Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
Health Care · Industrial Specialties · 108 employees
AZTA vs SMTI FAQ
Which is bigger, Azenta or Sanara MedTech?
Azenta (AZTA) is larger, with a market capitalization of $1.67B compared with $321.95M for Sanara MedTech (SMTI).
Which stock has performed better over the past year, AZTA or SMTI?
AZTA returned +11.70% over the past 12 months, compared with +8.41% for SMTI (price return, excluding dividends). Past performance does not predict future results.
Are Azenta and Sanara MedTech in the same industry?
No. Azenta is in the Technology sector, while Sanara MedTech is in Health Care.